| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 47 | 2022 | 232 | 10.650 |
Why?
|
| Water-Electrolyte Imbalance | 16 | 2022 | 29 | 5.080 |
Why?
|
| Extracorporeal Membrane Oxygenation | 15 | 2022 | 123 | 4.180 |
Why?
|
| Nephrotic Syndrome | 12 | 2022 | 61 | 3.640 |
Why?
|
| Quality of Life | 11 | 2019 | 1515 | 2.150 |
Why?
|
| Critical Illness | 14 | 2022 | 191 | 1.980 |
Why?
|
| Renal Replacement Therapy | 12 | 2022 | 40 | 1.920 |
Why?
|
| Infant, Newborn | 37 | 2022 | 2455 | 1.820 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 114 | 1.650 |
Why?
|
| Nephrology | 11 | 2022 | 43 | 1.620 |
Why?
|
| Intensive Care Units, Pediatric | 11 | 2020 | 101 | 1.610 |
Why?
|
| Child | 51 | 2022 | 6405 | 1.590 |
Why?
|
| Water-Electrolyte Balance | 6 | 2022 | 43 | 1.560 |
Why?
|
| Kidney Diseases | 9 | 2022 | 307 | 1.510 |
Why?
|
| Hypothermia, Induced | 6 | 2021 | 93 | 1.460 |
Why?
|
| Hospital Mortality | 9 | 2021 | 384 | 1.340 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2020 | 161 | 1.250 |
Why?
|
| Asphyxia Neonatorum | 3 | 2021 | 14 | 1.080 |
Why?
|
| Health Status | 3 | 2017 | 429 | 1.030 |
Why?
|
| Infant | 25 | 2022 | 2891 | 1.000 |
Why?
|
| Humans | 93 | 2023 | 68618 | 1.000 |
Why?
|
| Respiration, Artificial | 7 | 2022 | 190 | 0.980 |
Why?
|
| Child, Preschool | 24 | 2022 | 3187 | 0.960 |
Why?
|
| Retrospective Studies | 37 | 2022 | 7277 | 0.960 |
Why?
|
| Creatinine | 9 | 2022 | 243 | 0.930 |
Why?
|
| Risk Factors | 31 | 2023 | 5731 | 0.930 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2022 | 72 | 0.900 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 5 | 2023 | 43 | 0.900 |
Why?
|
| Adolescent | 32 | 2022 | 8912 | 0.880 |
Why?
|
| Renal Dialysis | 9 | 2022 | 174 | 0.840 |
Why?
|
| Self Report | 7 | 2019 | 371 | 0.840 |
Why?
|
| Infant, Premature | 5 | 2021 | 284 | 0.830 |
Why?
|
| Hypoxia-Ischemia, Brain | 4 | 2021 | 56 | 0.790 |
Why?
|
| Nutritional Requirements | 1 | 2021 | 57 | 0.750 |
Why?
|
| Male | 53 | 2022 | 37321 | 0.750 |
Why?
|
| Female | 51 | 2022 | 38074 | 0.740 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2021 | 72 | 0.740 |
Why?
|
| Critical Care | 5 | 2022 | 263 | 0.730 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2022 | 450 | 0.700 |
Why?
|
| Length of Stay | 11 | 2022 | 780 | 0.680 |
Why?
|
| Hospitalization | 5 | 2020 | 978 | 0.630 |
Why?
|
| Time Factors | 11 | 2020 | 4655 | 0.620 |
Why?
|
| Quality Improvement | 2 | 2021 | 413 | 0.600 |
Why?
|
| Kidney Glomerulus | 2 | 2022 | 155 | 0.540 |
Why?
|
| Kidney | 9 | 2022 | 945 | 0.540 |
Why?
|
| Prognosis | 9 | 2019 | 2093 | 0.520 |
Why?
|
| Kidney Transplantation | 8 | 2022 | 839 | 0.510 |
Why?
|
| Social Skills | 1 | 2015 | 14 | 0.500 |
Why?
|
| Research Subjects | 1 | 2015 | 45 | 0.500 |
Why?
|
| Severity of Illness Index | 8 | 2020 | 1851 | 0.500 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 42 | 0.470 |
Why?
|
| Infant, Premature, Diseases | 3 | 2019 | 85 | 0.460 |
Why?
|
| Treatment Outcome | 18 | 2022 | 7029 | 0.450 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 292 | 0.430 |
Why?
|
| Kidney Failure, Chronic | 5 | 2019 | 365 | 0.420 |
Why?
|
| Surveys and Questionnaires | 7 | 2017 | 2800 | 0.410 |
Why?
|
| Health Services | 1 | 2013 | 87 | 0.410 |
Why?
|
| Multiple Organ Failure | 2 | 2022 | 36 | 0.400 |
Why?
|
| Blood Component Removal | 2 | 2022 | 19 | 0.400 |
Why?
|
| Biomedical Research | 1 | 2015 | 310 | 0.400 |
Why?
|
| Cohort Studies | 6 | 2023 | 2358 | 0.390 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2022 | 38 | 0.390 |
Why?
|
| Gestational Age | 4 | 2022 | 389 | 0.390 |
Why?
|
| Patient Selection | 1 | 2015 | 592 | 0.390 |
Why?
|
| Fatigue | 4 | 2017 | 132 | 0.380 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2022 | 468 | 0.380 |
Why?
|
| Vitamin D | 1 | 2015 | 516 | 0.380 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 172 | 0.370 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 1054 | 0.360 |
Why?
|
| Biomarkers | 8 | 2022 | 1593 | 0.360 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 33 | 0.360 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2010 | 11 | 0.360 |
Why?
|
| Meningitis | 1 | 2010 | 23 | 0.350 |
Why?
|
| Birth Weight | 3 | 2019 | 186 | 0.350 |
Why?
|
| Lymphoma, B-Cell | 1 | 2010 | 40 | 0.350 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2021 | 11 | 0.350 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 1046 | 0.340 |
Why?
|
| Body Weight | 1 | 2011 | 554 | 0.330 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 76 | 0.320 |
Why?
|
| United States | 13 | 2020 | 7367 | 0.320 |
Why?
|
| Young Adult | 10 | 2022 | 5717 | 0.320 |
Why?
|
| Pain | 3 | 2017 | 472 | 0.310 |
Why?
|
| Incidence | 7 | 2019 | 1603 | 0.310 |
Why?
|
| Hospitals, Pediatric | 3 | 2021 | 114 | 0.310 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 121 | 0.310 |
Why?
|
| Risk Assessment | 4 | 2020 | 2007 | 0.300 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2022 | 113 | 0.290 |
Why?
|
| Fluid Therapy | 2 | 2020 | 59 | 0.280 |
Why?
|
| Linear Models | 4 | 2016 | 521 | 0.280 |
Why?
|
| Odds Ratio | 4 | 2021 | 880 | 0.280 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 371 | 0.270 |
Why?
|
| Glomerulonephritis | 2 | 2019 | 77 | 0.270 |
Why?
|
| Prospective Studies | 6 | 2022 | 3705 | 0.270 |
Why?
|
| Databases, Factual | 3 | 2020 | 622 | 0.270 |
Why?
|
| Proteinuria | 2 | 2017 | 136 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 240 | 0.260 |
Why?
|
| Depression | 4 | 2017 | 943 | 0.250 |
Why?
|
| Organ Dysfunction Scores | 2 | 2022 | 13 | 0.250 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 2279 | 0.250 |
Why?
|
| Patient Discharge | 2 | 2020 | 294 | 0.250 |
Why?
|
| Logistic Models | 6 | 2021 | 1420 | 0.240 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 202 | 0.240 |
Why?
|
| Anger | 2 | 2015 | 47 | 0.230 |
Why?
|
| Michigan | 4 | 2021 | 68 | 0.230 |
Why?
|
| North America | 3 | 2018 | 112 | 0.230 |
Why?
|
| Midwestern United States | 4 | 2015 | 36 | 0.220 |
Why?
|
| Annual Reports as Topic | 3 | 2018 | 12 | 0.220 |
Why?
|
| Heart Failure | 2 | 2022 | 1180 | 0.220 |
Why?
|
| Postoperative Complications | 4 | 2021 | 1615 | 0.220 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2022 | 15 | 0.210 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2022 | 34 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1070 | 0.210 |
Why?
|
| Health Information Systems | 1 | 2022 | 18 | 0.210 |
Why?
|
| Acute Disease | 2 | 2021 | 658 | 0.210 |
Why?
|
| Erythropoietin | 1 | 2022 | 96 | 0.200 |
Why?
|
| Acidosis, Lactic | 1 | 2022 | 6 | 0.200 |
Why?
|
| Caffeine | 2 | 2021 | 81 | 0.200 |
Why?
|
| Hypernatremia | 1 | 2021 | 7 | 0.200 |
Why?
|
| Survival Rate | 3 | 2020 | 1056 | 0.200 |
Why?
|
| Hyponatremia | 1 | 2021 | 20 | 0.200 |
Why?
|
| Metformin | 1 | 2022 | 63 | 0.200 |
Why?
|
| Parenteral Nutrition | 1 | 2021 | 39 | 0.190 |
Why?
|
| Drug Overdose | 1 | 2022 | 67 | 0.190 |
Why?
|
| Hypothermia | 1 | 2021 | 37 | 0.190 |
Why?
|
| Adult | 10 | 2022 | 21403 | 0.190 |
Why?
|
| Survival Analysis | 2 | 2020 | 714 | 0.190 |
Why?
|
| Goals | 1 | 2021 | 65 | 0.180 |
Why?
|
| Nutritional Status | 1 | 2021 | 112 | 0.180 |
Why?
|
| Lupus Nephritis | 1 | 2022 | 193 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 940 | 0.180 |
Why?
|
| Fluid Shifts | 1 | 2019 | 2 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.170 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 157 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 514 | 0.170 |
Why?
|
| Information Systems | 2 | 2016 | 45 | 0.160 |
Why?
|
| Canada | 1 | 2019 | 267 | 0.160 |
Why?
|
| Term Birth | 1 | 2018 | 12 | 0.160 |
Why?
|
| Edema | 1 | 2019 | 66 | 0.160 |
Why?
|
| India | 1 | 2018 | 41 | 0.160 |
Why?
|
| Nephrosis, Lipoid | 1 | 2018 | 9 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 378 | 0.160 |
Why?
|
| Citrates | 1 | 2018 | 7 | 0.160 |
Why?
|
| Sample Size | 2 | 2015 | 79 | 0.160 |
Why?
|
| Renal Agents | 1 | 2018 | 8 | 0.160 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 32 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 30 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2019 | 198 | 0.150 |
Why?
|
| ROC Curve | 3 | 2017 | 392 | 0.150 |
Why?
|
| Weight Gain | 1 | 2018 | 135 | 0.150 |
Why?
|
| Graft Rejection | 2 | 2018 | 458 | 0.150 |
Why?
|
| Pediatrics | 3 | 2015 | 341 | 0.150 |
Why?
|
| Endpoint Determination | 1 | 2017 | 82 | 0.150 |
Why?
|
| Age Factors | 2 | 2020 | 1864 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2017 | 37 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 4 | 2022 | 274 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 117 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2017 | 631 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2017 | 72 | 0.140 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2016 | 3 | 0.140 |
Why?
|
| Premature Birth | 1 | 2018 | 150 | 0.140 |
Why?
|
| Pseudohypoaldosteronism | 1 | 2016 | 4 | 0.140 |
Why?
|
| Anemia, Sickle Cell | 2 | 2017 | 364 | 0.140 |
Why?
|
| Amphotericin B | 1 | 2016 | 26 | 0.140 |
Why?
|
| Acyclovir | 1 | 2016 | 38 | 0.130 |
Why?
|
| Vancomycin | 1 | 2016 | 60 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 209 | 0.130 |
Why?
|
| Norwood Procedures | 1 | 2016 | 61 | 0.130 |
Why?
|
| Aminoglycosides | 1 | 2016 | 54 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 51 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2017 | 158 | 0.130 |
Why?
|
| Awards and Prizes | 1 | 2015 | 27 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2016 | 141 | 0.130 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 848 | 0.130 |
Why?
|
| Judgment | 1 | 2015 | 40 | 0.130 |
Why?
|
| Time | 1 | 2015 | 57 | 0.120 |
Why?
|
| Community-Institutional Relations | 1 | 2015 | 59 | 0.120 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2015 | 31 | 0.120 |
Why?
|
| Steroids | 1 | 2015 | 84 | 0.120 |
Why?
|
| Hypertension | 2 | 2014 | 1535 | 0.120 |
Why?
|
| Parathyroid Hormone | 1 | 2015 | 117 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 79 | 0.120 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 138 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.120 |
Why?
|
| Maternal Exposure | 1 | 2015 | 75 | 0.120 |
Why?
|
| Area Under Curve | 2 | 2014 | 238 | 0.120 |
Why?
|
| Anxiety | 1 | 2017 | 422 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 1140 | 0.120 |
Why?
|
| Palliative Care | 1 | 2016 | 271 | 0.120 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 148 | 0.110 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 306 | 0.110 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 168 | 0.110 |
Why?
|
| Registries | 1 | 2017 | 733 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2015 | 254 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2015 | 332 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2013 | 60 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 1026 | 0.110 |
Why?
|
| Prevalence | 4 | 2018 | 1619 | 0.110 |
Why?
|
| Intensive Care, Neonatal | 1 | 2012 | 38 | 0.110 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 442 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 58 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 319 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 445 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2077 | 0.090 |
Why?
|
| Consensus | 2 | 2022 | 211 | 0.090 |
Why?
|
| Pulse Therapy, Drug | 1 | 2010 | 5 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2022 | 250 | 0.090 |
Why?
|
| Cranial Nerve Diseases | 1 | 2010 | 14 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 1330 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 951 | 0.090 |
Why?
|
| Rituximab | 1 | 2010 | 61 | 0.090 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 129 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 767 | 0.080 |
Why?
|
| Drug Resistance | 2 | 2021 | 223 | 0.080 |
Why?
|
| Neoplasms | 2 | 2017 | 1667 | 0.080 |
Why?
|
| Internationality | 2 | 2019 | 74 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 2 | 2021 | 186 | 0.080 |
Why?
|
| Recurrence | 2 | 2022 | 948 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 468 | 0.070 |
Why?
|
| Biopsy | 2 | 2018 | 540 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 2223 | 0.060 |
Why?
|
| Infant Mortality | 2 | 2017 | 59 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 3259 | 0.060 |
Why?
|
| Information Dissemination | 2 | 2016 | 113 | 0.060 |
Why?
|
| Brain | 1 | 2015 | 2176 | 0.060 |
Why?
|
| Apolipoprotein L1 | 1 | 2023 | 16 | 0.050 |
Why?
|
| Aged | 3 | 2019 | 14862 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2023 | 51 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 62 | 0.050 |
Why?
|
| Ibuprofen | 1 | 2022 | 30 | 0.050 |
Why?
|
| Social Class | 1 | 2022 | 127 | 0.050 |
Why?
|
| Theophylline | 1 | 2021 | 22 | 0.050 |
Why?
|
| Lipocalin-2 | 1 | 2021 | 19 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2021 | 65 | 0.050 |
Why?
|
| Sclerosis | 1 | 2021 | 32 | 0.050 |
Why?
|
| Remission Induction | 1 | 2021 | 111 | 0.050 |
Why?
|
| Genotype | 1 | 2023 | 786 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 258 | 0.050 |
Why?
|
| Research | 1 | 2021 | 214 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2021 | 546 | 0.040 |
Why?
|
| Neonatology | 1 | 2019 | 29 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2022 | 343 | 0.040 |
Why?
|
| Infant, Extremely Premature | 1 | 2019 | 18 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 69 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 438 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2019 | 49 | 0.040 |
Why?
|
| Coma | 1 | 2018 | 17 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 50 | 0.040 |
Why?
|
| Mortality | 1 | 2019 | 163 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 39 | 0.040 |
Why?
|
| Research Report | 1 | 2018 | 35 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 850 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 130 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2019 | 170 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 222 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 536 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2018 | 344 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 219 | 0.030 |
Why?
|
| Allografts | 1 | 2016 | 63 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 39 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 792 | 0.030 |
Why?
|
| Systole | 1 | 2015 | 149 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 58 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 161 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 21147 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 121 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2015 | 238 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 109 | 0.030 |
Why?
|
| Rheumatic Diseases | 1 | 2015 | 35 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 507 | 0.030 |
Why?
|
| Feeding and Eating Disorders | 1 | 2016 | 106 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 331 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1038 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 737 | 0.030 |
Why?
|
| Weight Loss | 1 | 2016 | 319 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 931 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 92 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2014 | 152 | 0.030 |
Why?
|
| Software | 1 | 2015 | 418 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 711 | 0.030 |
Why?
|
| Hemofiltration | 1 | 2012 | 7 | 0.030 |
Why?
|
| Ultrafiltration | 1 | 2012 | 35 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 481 | 0.030 |
Why?
|
| Parents | 1 | 2015 | 312 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 596 | 0.030 |
Why?
|
| International Cooperation | 1 | 2012 | 88 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2015 | 867 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1553 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1753 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2011 | 10 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2011 | 16 | 0.020 |
Why?
|
| Asthma | 1 | 2015 | 345 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1342 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 500 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2334 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4848 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 20881 | 0.010 |
Why?
|